PRIORIX measles, mumps, and rubella live vaccine packaging

RECONSTITUTION

Ready to reconstitute

PRIORIX is supplied as a single-dose vial of Lyophilized Antigen Component, Live and an accompanying prefilled ungraduated syringe of Sterile Water Diluent Component (packaged without a needle)1

  • Only use the accompanying Sterile Water Diluent Component to reconstitute PRIORIX1
  • The reconstituted vaccine should be a clear peach- to fuchsia pink-colored vaccine suspension1
  • If not used immediately, store refrigerated (36°F-46°F.) Discard reconstituted vaccine if not used within 8 hours1

Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever suspension and container permit. If either of these conditions exists, the vaccine should not be administered.1

Steps for Reconstitution1

Reconstitution figure 1

Figure 1.

Hold the prefilled syringe of Sterile Water Diluent Component by the barrel and unscrew the syringe cap by twisting it counterclockwise. Align the needle to the axis of the syringe and attach by gently connecting the needle hub into the Luer Lock Adaptor (LLA) and rotate a quarter turn clockwise until you feel it lock.

Reconstitution figure 2

Figure 2.

Cleanse the Lyophilized Antigen Component, Live vial stopper. Transfer the entire contents of the prefilled syringe into the vial.

Reconstitution figure 3

Figure 3.

Shake the vial well until the powder is completely dissolved. Do not invert the vial while shaking.

Reconstitution figure 4

Figure 4.

After reconstitution, withdraw the entire contents of the reconstituted vaccine into the same syringe and after changing the needle, administer subcutaneously.

See more about reconstitution in the Reconstitution of PRIORIX video

INDICATION & IMPORTANT SAFETY INFO

INDICATION FOR PRIORIX

IMPORTANT SAFETY INFORMATION FOR PRIORIX

INDICATION FOR PRIORIX

PRIORIX is a vaccine indicated for active immunization for the prevention of measles, mumps, and rubella in individuals 12 months of age and older.

IMPORTANT SAFETY INFORMATION FOR PRIORIX

  • Contraindications for PRIORIX: Do not administer PRIORIX to individuals with a history of severe allergic reactions (eg, anaphylaxis) to any component of the vaccine or after a previous dose of any measles, mumps, and rubella virus-containing vaccine. Do not administer PRIORIX to individuals who are immunodeficient or immunosuppressed due to disease or medical therapy. These individuals are at risk of disseminated vaccine virus infection. Do not administer PRIORIX to individuals who are pregnant. Pregnancy should be avoided for 1 month after vaccination
  • Appropriate medical treatment used to manage immediate allergic reactions must be available in the event an acute anaphylactic reaction occurs following administration of PRIORIX
  • There is a risk of febrile seizures following immunization with PRIORIX
  • Thrombocytopenia and thrombocytopenic purpura have been reported following vaccination with PRIORIX
  • Syncope (fainting) can occur in association with administration of injectable vaccines, including PRIORIX. Procedures should be in place to avoid injury from fainting
  • The tip caps of the prefilled syringes of diluent contain natural rubber latex, which may cause allergic reactions
  • Vaccination with PRIORIX may not result in protection in all vaccine recipients
  • In clinical trials, the most commonly reported (≥10%) solicited adverse reactions were:
    • Age 12 through 15 months–local: pain (26%) and redness (25%); systemic: irritability (63%), loss of appetite (45%), drowsiness (45%), and fever (35%)
    • Age 4 through 6 years–local: pain (41%), redness (22%) and swelling (11%); systemic: loss of appetite (21%), drowsiness (27%), and fever (24%)
    • Age 7 years and older–local: pain (12%) and redness (12%)
  • Administration of immune globulins and other blood products concurrently with PRIORIX may interfere with the expected immune response to the vaccine
  • If a tuberculin test is to be done, it should be administered either any time before, simultaneously with, or at least 4 weeks after PRIORIX to avoid false-negative results

Please see full Prescribing Information for PRIORIX.

References

  1. Prescribing Information for PRIORIX.